3 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Archives of cardiovascular diseases
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le jeudi 5 septembre 2019
Doi : 10.1016/j.acvd.2019.06.006
Received : 10 Mars 2019 ;  accepted : 11 June 2019
Indications and results for hybrid interventions in patients with congenital heart disease
Indications et résultats des interventions hybrides dans les cardiopathies congénitales

David Kalfa a, Alejandro J. Torres b,
a Section of Congenital and Pediatric Cardiac Surgery, Division of Cardiac, Thoracic and Vascular Surgery, Children's Hospital of NewYork-Presbyterian/Columbia University Medical Center, 10032 New York, NY, United States 
b Pediatric Cardiology Department, Children's Hospital of New York-Presbyterian/Columbia University Medical Center, 3959, Broadway BH2N, 10032 New York, NY, United States 

Corresponding author.

A hybrid therapy or procedure is a new treatment modality that develops by combining therapies from different subspecialties. In congenital heart disease, a growing number of such procedures have been described in recent decades, as a result of increasing collaboration between surgeons and interventionalists. The ideas behind these therapies include enabling the performance of procedures of different complexity in a less invasive manner, shortening procedural times, avoiding cardiopulmonary bypass, facilitating vascular access and decreasing the number of complications associated with more invasive approaches. Over the years, hybrid therapy has gained a place as a widely accepted therapeutic option for the management of several conditions in high-risk patients with congenital heart disease.

The full text of this article is available in PDF format.

Un traitement hybride ou une procédure hybride est une nouvelle modalité thérapeutique qui se développe en combinant les approches thérapeutiques de différentes surspécialités. Dans les cardiopathies congénitales, un nombre croissant de ces procédures a été décrit au cours des dernières années, résultat d’une collaboration croissante entre chirurgiens et cardiologues interventionnels. L’idée sous-jacente est de réaliser des procédures de complexité variable de façon moins invasive en réduisant le temps des procédures, en évitant la circulation extracorporelle, en simplifiant l’accès vasculaire et en réduisant le nombre de complications en rapport avec des thérapeutiques plus invasives. Ainsi, ces thérapeutiques hybrides ont gagné une option thérapeutique de plus en plus proposée dans la prise en charge de différentes situations cliniques chez les patients à haut risque porteurs de cardiopathie congénitale.

The full text of this article is available in PDF format.

Keywords : Transcatheter, Hybrid procedure, Hypoplastic left ventricle, Perventricular

Mots clés : Percutané, Procédure hybride, Ventricule gauche hypoplasique

Abbreviations : CPB, HLHS, LV, MVSD, PA, PAB, PDA, RV, RVOT, TOE, VSD

© 2019  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline